COVID-19 Outbreak-Global Diabetes Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- 71271
- 22-Dec
- Biotechnology
- 129
- MRR
-
Report Details
Drugs used in diabetes treat diabetes mellitus by lowering the glucose level in the blood. With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents. There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors. The Diabetes Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform. In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Diabetes Drugs industry. Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain. In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy. The Diabetes Drugs market can be split based on product types, major applications, and important countries as follows: Key players in the global Diabetes Drugs market covered in Chapter 12: North China Pharmaceutical Group Corporation Novo Nordisk Taloph Huadong Medicine Boehringer Ingelheim GmbH Guangzhou Baiyun Mountain Sanofi Jumpcan Pharmacy Merck?Co Tianan Pharmaceutical Novartis MSD Takeda Hisun Pharmacy Dongbao Pharmaceutical Co.,LTD Gan & Lee KELUN Wanbang Biopharmaceuticals SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD Astrazeneca Ginwa In Chapter 4 and 14.1, on the basis of types, the Diabetes Drugs market from 2015 to 2025 is primarily split into: Glucagon-like peptide-1 (GLP-1) agonist Dipeptidyl-peptidase-4 (DPP-4) inhibitors Sodium glucose co-transporter 2 (SGLT2) inhibitors Insulin Others In Chapter 5 and 14.2, on the basis of applications, the Diabetes Drugs market from 2015 to 2025 covers: Type 1 Diabetes Type 2 Diabetes Gestational Diabetes Impaired Glucose Tolerance and Impaired Fasting Glycaemia Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14: North America (Covered in Chapter 7 and 14) United States Canada Mexico Europe (Covered in Chapter 8 and 14) Germany UK France Italy Spain Russia Others Asia-Pacific (Covered in Chapter 9 and 14) China Japan South Korea Australia India Southeast Asia Others Middle East and Africa (Covered in Chapter 10 and 14) Saudi Arabia UAE Egypt Nigeria South Africa Others South America (Covered in Chapter 11 and 14) Brazil Argentina Columbia Chile Others Years considered for this report: Historical Years: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2020-2025
-
Table Of Content
Table of Content 1 Diabetes Drugs Introduction and Market Overview 1.1 Objectives of the Study 1.2 Overview of Diabetes Drugs 1.3 Scope of The Study 1.3.1 Key Market Segments 1.3.2 Players Covered 1.3.3 COVID-19's impact on the Diabetes Drugs industry 1.4 Methodology of The Study 1.5 Research Data Source 2 Executive Summary 2.1 Market Overview 2.1.1 Global Diabetes Drugs Market Siz
-
Inquiry Before Buying
-
Request Sample